68 related articles for article (PubMed ID: 17050804)
1. Human chorionic gonadotropin modulates prostate cancer cell survival after irradiation or HMG CoA reductase inhibitor treatment.
Yacoub A; Hawkins W; Hanna D; Young H; Park MA; Grant M; Roberts JD; Curiel DT; Fisher PB; Valerie K; Grant S; Hagan MP; Dent P
Mol Pharmacol; 2007 Jan; 71(1):259-75. PubMed ID: 17050804
[TBL] [Abstract][Full Text] [Related]
2. Human chorionic gonadotropin (hCG) interacts with lovastatin and ionizing radiation to modulate prostate cancer cell viability in vivo.
Hamed H; Mitchell C; Park MA; Hanna D; Martin AP; Harrison B; Hawkins W; Curiel DA; Fisher PB; Grant S; Yacoub A; Hagan MP; Dent P
Cancer Biol Ther; 2008 Apr; 7(4):587-93. PubMed ID: 18379195
[TBL] [Abstract][Full Text] [Related]
3. Lovastatin sensitizes lung cancer cells to ionizing radiation: modulation of molecular pathways of radioresistance and tumor suppression.
Sanli T; Liu C; Rashid A; Hopmans SN; Tsiani E; Schultz C; Farrell T; Singh G; Wright J; Tsakiridis T
J Thorac Oncol; 2011 Mar; 6(3):439-50. PubMed ID: 21258249
[TBL] [Abstract][Full Text] [Related]
4. Caspase-7 is activated during lovastatin-induced apoptosis of the prostate cancer cell line LNCaP.
Marcelli M; Cunningham GR; Haidacher SJ; Padayatty SJ; Sturgis L; Kagan C; Denner L
Cancer Res; 1998 Jan; 58(1):76-83. PubMed ID: 9426061
[TBL] [Abstract][Full Text] [Related]
5. Low-dose BBR3610 toxicity in colon cancer cells is p53-independent and enhanced by inhibition of epidermal growth factor receptor (ERBB1)-phosphatidyl inositol 3 kinase signaling.
Mitchell C; Kabolizadeh P; Ryan J; Roberts JD; Yacoub A; Curiel DT; Fisher PB; Hagan MP; Farrell NP; Grant S; Dent P
Mol Pharmacol; 2007 Sep; 72(3):704-14. PubMed ID: 17578896
[TBL] [Abstract][Full Text] [Related]
6. Lamin B, caspase-3 activity, and apoptosis induction by a combination of HMG-CoA reductase inhibitor and COX-2 inhibitors: a novel approach in developing effective chemopreventive regimens.
Swamy MV; Cooma I; Reddy BS; Rao CV
Int J Oncol; 2002 Apr; 20(4):753-9. PubMed ID: 11894121
[TBL] [Abstract][Full Text] [Related]
7. Modulation of radiation response by histone deacetylase inhibition.
Chinnaiyan P; Vallabhaneni G; Armstrong E; Huang SM; Harari PM
Int J Radiat Oncol Biol Phys; 2005 May; 62(1):223-9. PubMed ID: 15850925
[TBL] [Abstract][Full Text] [Related]
8. The novel antimicrotubule agent cryptophycin 52 (LY355703) induces apoptosis via multiple pathways in human prostate cancer cells.
Drew L; Fine RL; Do TN; Douglas GP; Petrylak DP
Clin Cancer Res; 2002 Dec; 8(12):3922-32. PubMed ID: 12473608
[TBL] [Abstract][Full Text] [Related]
9. Long-term androgen-ablation causes increased resistance to PI3K/Akt pathway inhibition in prostate cancer cells.
Pfeil K; Eder IE; Putz T; Ramoner R; Culig Z; Ueberall F; Bartsch G; Klocker H
Prostate; 2004 Feb; 58(3):259-68. PubMed ID: 14743465
[TBL] [Abstract][Full Text] [Related]
10. Statin induces apoptosis and cell growth arrest in prostate cancer cells.
Hoque A; Chen H; Xu XC
Cancer Epidemiol Biomarkers Prev; 2008 Jan; 17(1):88-94. PubMed ID: 18199714
[TBL] [Abstract][Full Text] [Related]
11. Human chorionic gonadotropin up-regulates expression of myeloid cell leukemia-1 protein in human granulosa-lutein cells: implication of corpus luteum rescue and ovarian hyperstimulation syndrome.
Chen SU; Chen RJ; Shieh JY; Chou CH; Lin CW; Lu HF; Yang YS
J Clin Endocrinol Metab; 2010 Aug; 95(8):3982-92. PubMed ID: 20444920
[TBL] [Abstract][Full Text] [Related]
12. Apoptosis induction in prostate cancer cells and xenografts by combined treatment with Apo2 ligand/tumor necrosis factor-related apoptosis-inducing ligand and CPT-11.
Ray S; Almasan A
Cancer Res; 2003 Aug; 63(15):4713-23. PubMed ID: 12907654
[TBL] [Abstract][Full Text] [Related]
13. The phosphatidylinositol 3'-kinase pathway is a dominant growth factor-activated cell survival pathway in LNCaP human prostate carcinoma cells.
Lin J; Adam RM; Santiestevan E; Freeman MR
Cancer Res; 1999 Jun; 59(12):2891-7. PubMed ID: 10383151
[TBL] [Abstract][Full Text] [Related]
14. Lovastatin causes diminished PSA secretion by inhibiting AR expression and function in LNCaP prostate cancer cells.
Yang L; Egger M; Plattner R; Klocker H; Eder IE
Urology; 2011 Jun; 77(6):1508.e1-7. PubMed ID: 21624609
[TBL] [Abstract][Full Text] [Related]
15. HMGN5 knockdown sensitizes prostate cancer cells to ionizing radiation.
Su B; Shi B; Tang Y; Guo Z; Yu X; He X; Li X; Gao X; Zhou L
Prostate; 2015 Jan; 75(1):33-44. PubMed ID: 25307178
[TBL] [Abstract][Full Text] [Related]
16. Prenyltransferase inhibitors induce apoptosis in proliferating thyroid cells through a p53-independent CrmA-sensitive, and caspase-3-like protease-dependent mechanism.
Vitale M; Di Matola T; Rossi G; Laezza C; Fenzi G; Bifulco M
Endocrinology; 1999 Feb; 140(2):698-704. PubMed ID: 9927296
[TBL] [Abstract][Full Text] [Related]
17. Gonadotropin-mediated chemoresistance: Delineation of molecular pathways and targets.
Sahoo S; Singh P; Kalha B; Singh O; Pal R
BMC Cancer; 2015 Nov; 15():931. PubMed ID: 26608647
[TBL] [Abstract][Full Text] [Related]
18. OSU-03012 promotes caspase-independent but PERK-, cathepsin B-, BID-, and AIF-dependent killing of transformed cells.
Yacoub A; Park MA; Hanna D; Hong Y; Mitchell C; Pandya AP; Harada H; Powis G; Chen CS; Koumenis C; Grant S; Dent P
Mol Pharmacol; 2006 Aug; 70(2):589-603. PubMed ID: 16622074
[TBL] [Abstract][Full Text] [Related]
19. Lovastatin inhibits the growth and survival pathway of phosphoinositide 3-kinase/protein kinase B in immortalized rat brain neuroblasts.
Cerezo-Guisado MI; Garcia-Marin LJ; Lorenzo MJ; Bragado MJ
J Neurochem; 2005 Sep; 94(5):1277-87. PubMed ID: 16111478
[TBL] [Abstract][Full Text] [Related]
20. Role of RhoA activation in the growth and morphology of a murine prostate tumor cell line.
Ghosh PM; Ghosh-Choudhury N; Moyer ML; Mott GE; Thomas CA; Foster BA; Greenberg NM; Kreisberg JI
Oncogene; 1999 Jul; 18(28):4120-30. PubMed ID: 10435593
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
